title: Cholestatic hepatitis associated with repaglinide.
authors.forename: Francisco
authors.initials: F
authors.lastname: López-García
authors.forename: Joaquín
authors.initials: J
authors.lastname: Borrás
authors.forename: Clara
authors.initials: C
authors.lastname: Verdú
authors.forename: V R
authors.initials: VR
authors.lastname: Salazar
authors.forename: J Antonio
authors.initials: JA
authors.lastname: Ruiz
authors.forename: Jorge
authors.initials: J
authors.lastname: Sales
authors.forename: M Isabel
authors.initials: MI
authors.lastname: Lucena
authors.forename: Raúl J
authors.initials: RJ
authors.lastname: Andrade
mesh_terms: D000368:Aged; D002219:Carbamates / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002779:Cholestasis / Q000139:chemically induced*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D010880:Piperidines / Q000009:adverse effects*
chemical_list: D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; C072379:repaglinide